Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.


L-3,4-dihydroxyphenylalanine (L-dopa) has been the gold standard for pharmacotherapy for parkinsonism in patients with dementia with Lewy bodies (DLB). While L-dopa treatment is related to visual hallucinations, its relationship to mood fluctuation in DLB is poorly understood. Herein, we report the improvement of behavioural and psychological symptoms of… (More)
DOI: 10.1111/psyg.12025

2 Figures and Tables


  • Presentations referencing similar topics